Companies: 10,795·Total market cap: $144.5T
Zai Lab Limited

Zai Lab Limited

ZLABNASDAQHealthcare● Active
$16.72
+$0.10(+0.57%)
Market Cap$1.9B
P/E Ratio—
52W High$44.34
52W Low$15.96
Cash on HandFinancialsRevenue

Zai Lab Limited (ZLAB) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ZLAB · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$689.6M▼ -11.6% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$679.6M
cashAndCashEquivalents
Short-Term Investments
$10.0M
shortTermInvestments
YoY Change vs Prior Year
-11.6%
vs prior fiscal year
Latest Quarter
$661.3M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$689.6MCash on Hand
Total Debt$224.3MTotal Debt
Net Cash / Net Debt+$465.3MNet Cash Position
Cash vs Debt Ratio
Cash 75%Debt 25%

Zai Lab Limited has a net cash position of $465.3M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$689.6M − $224.3M = +$465.3M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
ZLAB annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$689.6M-11.6%
Dec 31, 2024$779.7M-3.3%
Dec 31, 2023$806.5M-20.0%
Dec 31, 2022$1.01B-28.4%
Dec 31, 2021$1.41B+18.7%
ZLAB cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Zai Lab Limited
Zai Lab LimitedYOU
ZLAB
$689.6M36.7%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Zai Lab Limited (ZLAB) cash on hand as of December 31, 2025 is $689.6M, comprising $679.6M in cash and cash equivalents (CCE) plus $10.0M in short-term investments — reported as Zai Lab Limited cash and short-term investments on the balance sheet (10-K filing). Also referred to as Zai Lab Limited cash reserves or cash position.

Zai Lab Limited annual cash on hand history shows decreased -11.6% in 2025: decreased -11.6% in 2025. Zai Lab Limited cash reserves in 2025 reflect the company's capital allocation strategy.

Zai Lab Limited carries total debt of $224.3M against cash of $689.6M, resulting in a net cash position of +$465.3M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

ZLAB cash on hand · 5 questions

As of December 31, 2025, Zai Lab Limited (ZLAB) has $689,573,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $679,573,000 in cash and cash equivalents (CCE) plus $10,000,000 in short-term investments. Latest quarter (March 31, 2026): $661,316,000. Data sourced from the annual 10-K filing via FMP.

ZLAB cash on handZLAB cash reservesZLAB cash 2025how much cash does ZLAB have

▸ Source: FMP /balance-sheet-statement · US GAAP · Zai Lab Limited · Zai Lab Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025